Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT05262426

Developing mHealth to Promote PrEP Use Among Thai Young Vulnerable Adolescents and Emerging Adults

The main aim of this study is to develop technology-based interventions to improve HIV pre-exposure prophylaxis (PrEP) uptake and adherence among Thai young transgender women.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Age range

16 year–29 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Institute of HIV Research and Innovation, Bangkok, Thailand

Loading trial locations.

About this study

Motivational Enhancement System for Adherence (MESA) is a computer-based motivation invention, based on the Information-Motivation-Behavioral Skills (IMB) model and Motivational Interviewing (MI) principles, used to promote adherence among HIV-positive youth initiating antiretroviral treatment. In this study, the team will adapt and develop MESA to focus on PrEP uptake and adherence, which will be called Motivational Enhancement System for PrEP Uptake and Adherence (MES-PrEP). YaCool is a mobile application developed to support transgender women self-management of gender and sexual health, including PrEP use.

In Aim 1, the investigators will begin with needs assessment to evaluate intervention efficacy by exploring the barriers and facilitators of PrEP uptake and adherence through in-depth interviews with transgender women and community health workers. The two interventions will be developed and refined based upon the inputs from transgender women through focus group discussion and community advisory board.

In Aim 2, the investigators will conduct a Multiphase Optimization Strategy (MOST) design-based trial to evaluate the feasibility, acceptability, and preliminary efficacy of MES-PrEP and Enhanced YaCool and to determine whether MES-PrEP works better when combined with Enhanced YaCool to improve PrEP use. Eligible transgender women will be randomized to one of the four experimental conditions, and followed for 12 months with assessments at baseline, month 1, 3, 6, 9 and 12.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Aim 1:

Transgender women participants

Inclusion criteria

  • Age 16-29 years old
  • Male sex at birth
  • Self-identifies as woman or transgender women or culturally identifies with the female spectrum
  • Confirmed HIV-negative status
  • Self-reported recent history of condomless sex in the past 6 months
  • Able to understand, read and speak Thai
  • Either having not started PrEP (Group 1: PrEP naive), currently on PrEP but not adherent to PrEP (taking ≤3 pills/week) in the past month (Group 2: PrEP users) or currently on PrEP with good adherence (Group 3: PrEP users with good adherence).

Exclusion criteria

  • Have a serious cognitive or psychiatric problem that would compromise ability to provide informed consent
  • Have active suicidal ideation or major mental illness (e.g., untreated psychosis or mania) at the time of interview (patients will be referred for treatment)
  • Laboratory or clinical findings that would preclude PrEP initiation (e.g., decreased creatinine clearance)

Healthcare providers

Inclusion criteria

  • Have at least 1-year experience working with HIV-negative transgender women, including providing PrEP prescription and counseling

Exclusion criteria

  • None

Aim 2:

Inclusion criteria

  • Age 16-29 years old
  • Male sex at birth
  • Self-identifies as woman or transgender women or culturally identifies with the female spectrum
  • Confirmed HIV-negative status
  • Self-reported recent history of condomless sex in the past 6 months
  • Able to understand, read and speak Thai
  • Either having not started PrEP (Group 1: PrEP naive), currently on PrEP but not adherent to PrEP (taking ≤3 pills/week) in the past month (Group 2: PrEP users).

Exclusion criteria

  • Have a serious cognitive or psychiatric problem that would compromise ability to provide informed consent
  • Have active suicidal ideation or major mental illness (e.g., untreated psychosis or mania) at the time of interview (patients will be referred for treatment)
  • Laboratory or clinical findings that would preclude PrEP initiation (e.g., decreased creatinine clearance)
  • Currently enrolled in another HIV intervention study

Treatment and study plan

Behavioral: Motivational Enhancement System for PrEP Uptake and Adherence (MES-PrEP)

Behavioral

MES-PrEP is a two-session computer-delivered intervention based on IMB model. The intervention is tailored based on the person's ratings of perceived importance and confidence of initiating PrEP and sustaining adherence to PrEP. Participants are routed to different intervention content based on their assessment of their importance and confidence. Youth are provided with feedback on scores on the knowledge assessment followed by information about protective effect that can result from improved PrEP adherence. Finally, participants are asked to set a goal: obtain PrEP prescription, optimal adherence, practice steps, or thinking about it more, and they form plans for overcoming barriers. In the second session, branches are based on whether the youth felt they met the goal, partially met the goal, or did not meet the goal. Sessions of MES-PrEP will occur at baseline and month 1.

Enhanced YaCool

Behavioral

Enhanced YaCool is mobile application developed to support transgender women self-management of their gender and sexual health, including PrEP use. YaCool is a passcode-protected app that allows users to personalized text messaged reminders to take PrEP and/or clinic appointments, record PrEP adherence and sexual activity, and track lab tests. The application is set up to provide personalized recommendations for PrEP regimen, confirmed by clinic healthcare staff. Participants will be asked to download Enhanced YaCool to support PrEP use and gender/sexual health self-management between MES-PrEP sessions for 30 days, and thereafter until the end of Month 12 (if desired).

Standard PrEP Counseling

Behavioral

All participants will received one-on-one, face to face counseling from lay providers at baseline, months 1, 3, 6, 9 and 12. Standard PrEP counseling includes sexual and behavioral risk assessment for HIV/STIs and risk reduction. For those not on PrEP, the sessions will focus on risk perception, awareness of PrEP/post-exposure prophylaxis (PEP) and facilitators and barriers of accessing PrEP. For those on PrEP, the sessions will focus on adherence. Standard counseling sessions will be nonjudgmental, non-discriminatory and client-centered.

Primary outcomes

  1. Intervention Acceptability: System Usability Score

    Time frame: Month 3

    System Usability Score (SUS) is a 10-item, Likert scale used to calculate intervention usability. Each item ranges from 0 to 4 (with 4 being the most positive response). For odd-numbered items, the score is calculated by subtracting one from the user response. For even-numbered items, the score is calculated by subtracting the user response from 5. Then sum the total score and multiply that by 2.5. The overall SUS scores range from 0 to 100. A score of > 50 indicates that the technology-based interventions are acceptable.

  2. Intervention Acceptability: System Usability Score

    Time frame: Month 6

    System Usability Score (SUS) is a 10-item, Likert scale used to calculate intervention usability. Each item ranges from 0 to 4 (with 4 being the most positive response). For odd-numbered items, the score is calculated by subtracting one from the user response. For even-numbered items, the score is calculated by subtracting the user response from 5. Then sum the total score and multiply that by 2.5. The overall SUS scores range from 0 to 100. A score of > 50 indicates that the technology-based interventions are acceptable.

  3. Intervention Acceptability: Client Satisfaction Questionnaire

    Time frame: Month 3

    Client Satisfaction Questionnaire (CSQ-8) is an 8-items, Likert scale measuring the construct of global intervention satisfaction. The total possible composite score range from 8 to 32, with higher scores indicating a greater degree of acceptability.

  4. Intervention Acceptability: Client Satisfaction Questionnaire

    Time frame: Month 6

    Client Satisfaction Questionnaire (CSQ-8) is an 8-items, Likert scale measuring the construct of global intervention satisfaction. The total possible composite score range from 8 to 32, with higher scores indicating a greater degree of acceptability.

  5. Intervention Acceptability: Exit Interview

    Time frame: Month 1

    Intervention acceptability will be assess by the number of positive responses based on the exit interviews administered at month 1. Participants will be asked to provide feedback on experiences using MES-PrEP and enhanced YaCool, acceptability and ease of use, suggestions for improvement, role in PrEP uptake and adherence, and interest in continued intervention use, as well as experiences following a PrEP regimen, reasons for discontinuation of PrEP, and additional tools that would assist them in taking PrEP.

  6. Intervention Feasibility: Number of responses to text messages

    Time frame: Baseline through Month 12

    Intervention feasibility will be measured by total number of responses to and frequency of usage of Enhanced YaCool. Point estimates of >50% of participants responded to Enhanced YaCool at least once is considered as the minimum criteria for feasibility.

  7. Intervention Feasibility: Number of intervention sessions completed

    Time frame: Baseline through Month 12

    Intervention feasibility will be measured by number of intervention sessions completed. Point estimates of >50% of participants completed at least one intervention session is considered as the minimum criteria for feasibility.

  8. Intervention Feasibility: Participant retention

    Time frame: Baseline through Month 6

    Intervention Feasibility will be measured by participants retention rate at Month 6. Retention rate of >85% at month 6 is considered as the minimum criteria for feasibility.

  9. PrEP Adherence: Visual analog scale

    Time frame: Baseline through Month 12

    PrEP adherence will be measured from Young Adult Adherence Interview via computer-assisted self-interview (CASI) survey which contains a visual analog scale (VAS). VAS ranges from 0 to 100, with higher percentage indicating greater adherence to PrEP.

  10. PrEP Adherence: Self-reported adherence

    Time frame: Baseline through Month 12

    PrEP adherence will be measured from self-reported adherence to PrEP in the past 4 weeks via CASI survey. The scale ranges from 0 to 100%, with higher percentage indicating greater adherence to PrEP. The result of this self-reported adherence will be triangulated with the results of dried blood spots testing.

  11. PrEP Adherence: Dried blood spots

    Time frame: Baseline through Month 12

    PrEP adherence will be measured by the level of tenofovir in dried blood spots (DBS). DBS report on 80% Truvada adherence after at least three weeks of regular adherence.

  12. PrEP Uptake

    Time frame: Month 1 through Month 12

    PrEP uptake will be measured by the number of PrEP prescription, using a self-report measure (participants reporting if they left the clinic with PrEP) and confirming with clinic records.

Secondary outcomes

  1. PrEP Knowledge

    Time frame: Baseline to Month 12

    Knowledge of PrEP will be measured using the 13-item PrEP knowledge scale. The total possible score is 13, with higher scores indicating a greater degree of PrEP knowledge.

  2. HIV Knowledge

    Time frame: Baseline to Month 12

    Knowledge of HIV transmission risk will be assessed using am 18-item HIV Knowledge Questionnaire. The total possible composite score range from 0 to 18, with higher scores indicating a greater degree of HIV knowledge.

  3. Motivation: Rollnick's Readiness Ruler

    Time frame: Baseline to Month 12

    Behavioral intentions will be measured using 5-item Rollnick's Readiness Ruler, which correspond to PrEP uptake and adherence. Each item ranges from 0 to 10, with higher numbers indicate greater readiness for change.

  4. Motivation: Decisional Balance for PrEP Use

    Time frame: Baseline to Month 12

    Attitude towards PrEP will be measured using 36-item Decisional Balance for PrEP Use. The 5-point Likert scale assesses the pros and cons of PrEP use and is helpful in understanding cognitive and motivational aspects of decision making.

  5. Behavior skills

    Time frame: Baseline to Month 12

    Behavior skills will be assessed using the 8-item adapted version of Self-Efficacy for Health Promotion and Risk Reduction Questionnaire. The 5-point Likert scale assesses the confidence in using a condom, taking PrEP as recommended and getting PrEP refills. The total possible score is 40, with higher scores indicating a greater confidence for each item.

  6. HIV Status

    Time frame: Baseline to Month 12

    HIV status based on 4th generation HIV-1/2 antigen/antibody combo testing.

  7. Sexually Transmitted Infections (STIs) Diagnosis

    Time frame: Baseline to Month 12

    STI diagnosis based on treponemal test with rapid plasma reagin (RPR) confirmation for syphilis. Pooled urine, oropharyngeal and rectal swabs for gonorrhea and chlamydia nucleic acid amplification test (NAAT) testing.

  8. Sexual Risk

    Time frame: Baseline to Month 12

    Sexual risk will be assessed through Timeline Followback via CASI, which collects sexual behavior in the past 30 days, including questions about condom use and number of sexual partners.

Other outcomes

  1. Drug/Alcohol Use: ASSIST

    Time frame: Baseline to Month 12

    Drug/Alcohol Use will be assessed using Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) developed by the World Health Organization (WHO). ASSIST is a questionnaire that is used for identification of substance use related health risks and substance use disorders. Each item ranges from 0-12, with 0 reflecting low risk score. The total possible score is 24, with higher number indicating higher risk of health and other problems based from the current pattern of substance use.

  2. Drug/Alcohol Use: AUDIT-C

    Time frame: Baseline to Month 12

    Alcohol Use Disorders Identification Test (AUDIT-C) or a brief alcohol screening instrument will also be used to identify persons who are hazardous drinkers or have active alcohol use disorders (including alcohol abuse or dependence). Each item ranges from 0 to 4, with 0 reflecting no alcohol use. The total possible score is 12, with higher number indicating higher drink above recommended limits and are at increased risks for harm.

  3. Mental Health

    Time frame: Baseline to Month 12

    Mental Health will be assessed using the 12-item Thai General Health Questionnaire. The 4-point Likert scale measures psychological distress such as depression, anxiety, social impartment and somatic complaints. The total possible score is 48, with higher scores indicating higher severity of psychological distress.

  4. Perceived HIV risk

    Time frame: Baseline to Month 12

    Perceived HIV risk will be measured using the 8-item Perceived Risk of HIV Scale. All items are rated on a 4-point Likert scale. The total possible score is 40, with higher scores indicating higher perception of HIV risk.

  5. Social support

    Time frame: Baseline to Month 12

    Social support will be assessed using the 13-item Social Provision Scale (SPS). The 5-point Likert scale measures the availability of social support, including emotional support, information support, instrumental support, companionship and social isolation. The total possible score is 65, with higher scores indicating greater availability of social support.

  6. PrEP stigma

    Time frame: Baseline to Month 12

    PrEP-related stigma will be assessed using the 10-item PrEP stigma and positive attitudes scale. The 5-point Likert scale measures opinions about PrEP. Higher scores indicate higher perceived stigma related to PrEP.

Sponsors and collaborators

Lead sponsor

University of Massachusetts, Worcester

Other

Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
  • Institute of HIV Research and Innovation Foundation, Thailand
  • Wayne State University

Registry information

Official study title

Optimizing an mHealth Intervention to Improve Uptake and Adherence of the HIV Pre-exposure Prophylaxis (PrEP) in Vulnerable Adolescents and Emerging Adults

Important dates

Study start
2021
Primary completion
2026
Study completion
2026
First posted
Mar 2, 2022
Registry last updated
Mar 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.